Tag Archives: Intellia

How CRISPR gene editing will treat diseases in future: Nobel-winning Intellia co-founder Jennifer Doudna

Gene-editing technology CRISPR reached a major milestone this past weekend, completing its first systemic delivery as a medicine to a human body. CRISPR, or clustered regularly interspaced short palindromic repeats, effectively cuts genomes and slices DNA to treat genetic diseases. The latest breakthrough, the result of a trial between biotech company Regeneron and Boston-based startup… Read More »